Document Detail

Laser indirect ophthalmoscope photocoagulation in an incubator for the treatment of retinopathy of prematurity.
MedLine Citation:
PMID:  8152733     Owner:  NLM     Status:  MEDLINE    
Argon blue-green or diode laser indirect ophthalmoscope photocoagulation, performed through the transparent wall of an incubator, was used to treat threshold retinopathy of prematurity in two premature infants who were in poor systemic condition and could not be treated out of the incubator. Despite technical difficulties posed in one or both cases by their lateral position, small pupils, persistent tunica vasculosa lentis, and hazy cornea, there were no systemic complications and the retinopathy regressed in both cases.
S Tanaka
Related Documents :
21342253 - Ten-year quality assurance of the nationwide hearing screening programme in dutch neona...
10224603 - Basic aspects of prematurity prevention and results achieved by a suitable, simple prog...
11665323 - The management and outcome of higher order multifetal pregnancies: obstetric, neonatal ...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Ophthalmic surgery     Volume:  25     ISSN:  0022-023X     ISO Abbreviation:  Ophthalmic Surg     Publication Date:  1994 Jan 
Date Detail:
Created Date:  1994-05-09     Completed Date:  1994-05-09     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0241035     Medline TA:  Ophthalmic Surg     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  48-50     Citation Subset:  IM    
Department of Ophthalmology, University of Tokyo School of Medicine, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Gestational Age
Incubators, Infant*
Infant, Low Birth Weight
Infant, Newborn
Infant, Premature
Iris / pathology
Laser Coagulation / methods*
Retinopathy of Prematurity / surgery*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Normal eyelid crease position in children.
Next Document:  The use of subconjunctivally administered tissue plasminogen activator after trabeculectomy.